Nolato AB (publ) (NOLA_B) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nolato Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.797 Hello and welcome to today's presentation with Nolato. 00:00:03.797 -- 00:00:08.826 With us presenting today, we have the CEO, Christer Wallquist, and CFO, 00:00:08.826 -- 00:00:13.574 Per-Ola Holmström. If you have any questions and you're calling in, please press star 00:00:13.574 -- 00:00:19.083 nine to raise your hand and then star six to mute yourself when it's your turn to speak. 00:00:19.083 -- 00:00:22.749 You can also submit your written questions via the form located to the right. 00:00:22.749 -- 00:00:26.512 And with that said, please go ahead with your presentation. 00:00:27.166 -- 00:00:31.454 Thank you and welcome to the presentation of Nolato's first quarter 2025. 00:00:31.454 -- 00:00:35.919 This is Chris DeWalkwist speaking. 00:00:36.323 -- 00:00:38.788 If we summarize the quarter, 00:00:38.788 -- 00:00:43.356 we had similar sales as comparison quarter, 00:00:43.356 -- 00:00:48.666 but with a very strong increase of our margins amounting 00:00:48.666 -- 00:00:53.908 to 11% as a total. creating an EBITDA 00:00:53.908 -- 00:00:55.469 on 00:00:55.469 -- 00:00:58.752 271 million. 00:00:58.752 -- 00:01:00.574 We saw 00:01:00.574 -- 00:01:04.317 growth within the medical, but slightly 00:01:04.317 -- 00:01:10.161 lower sales for engineered solution due to the automotive sector. 00:01:10.163 -- 00:01:15.768 If we look on the margins, we strengthened the margins in both business areas, but particularly 00:01:15.768 -- 00:01:19.429 strong performance for medical solutions. 00:01:19.512 -- 00:01:25.300 Still, we have a very strong financial position with net financial liabilities 00:01:25.300 -- 00:01:29.385 in relation to adjusted operating profit of 0.5 00:01:29.385 -- 00:01:31.385 times. 00:01:32.430 -- 00:01:36.195 Movin...